磷酸化Bcl-2抗体Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BCL2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma.磷酸化Bcl-2抗体Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1).磷酸化Bcl-2抗体 It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, and is necessary for anti-apoptotic activity. Also interacts with APAF1, RAF1, TP53BP2, BBC3, BCL2L1 and BNIPL.
磷酸化Bcl-2抗体Also known as:
Bcl2 (phospho T56); Bcl2 (phospho Thr56); p-Bcl2 (phospho T56); Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Bcl-2 around the phosphorylation site of Thr56.
●
磷酸化Bcl-2抗体Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
l748Hu01亲核素α2(KPNα2)多克隆抗体Polyclonal Antibody to Karyopherin Alpha 2 (KPNa2)
kl762Hu01干扰素γ诱导蛋白30(IFI30)多克隆抗体Polyclonal Antibody to Interferon Gamma Inducible Protein 30 (IFI30)
kl765Hu01白介素23受体(IL23R)多克隆抗体Polyclonal Antibody to Interleukin 23 Receptor (IL23R)
kl765Ra01白介素23受体(IL23R)多克隆抗体Polyclonal Antibody to Interleukin 23 Receptor (IL23R)
kl767Hu01白介素22受体α2(IL22Rα2)多克隆抗体Polyclonal Antibody to Interleukin 22 Receptor Alpha 2 (IL22Ra2)
kl767Mu01白介素22受体α2(IL22Rα2)多克隆抗体Polyclonal Antibody to Interleukin 22 Receptor Alpha 2 (IL22Ra2)
kl767Ra01白介素22受体α2(IL22Rα2)多克隆抗体Polyclonal Antibody to Interleukin 22 Receptor Alpha 2 (IL22Ra2)
kl777Hu01免疫球蛋白A2(IgA2)多克隆抗体Polyclonal Antibody to Immunoglobulin A2 (IgA2)
kl778Hu01免疫球蛋白A1(IgA1)多克隆抗体Polyclonal Antibody to Immunoglobulin A1 (IgA1)
kl779Hu01膜联蛋白A9(ANXA9)多克隆抗体Polyclonal Antibody to Annexin A9 (ANXA9)
kl780Hu01膜联蛋白A10(ANXA10)多克隆抗体Polyclonal Antibody to Annexin A10 (ANXA10)
kl781Hu01膜联蛋白A11(ANXA11)多克隆抗体Polyclonal Antibody to Annexin A11 (ANXA11)
kl784Hu01膜联蛋白A4(ANXA4)多克隆抗体Polyclonal Antibody to Annexin A4 (ANXA4)
kl786Hu01膜联蛋白A3(ANXA3)多克隆抗体Polyclonal Antibody to Annexin A3 (ANXA3)
kl787Hu01膜联蛋白A1(ANXA1)多克隆抗体Polyclonal Antibody to Annexin A1 (ANXA1)
kl787Mu01膜联蛋白A1(ANXA1)多克隆抗体Polyclonal Antibody to Annexin A1 (ANXA1)
kl801Ra01AMPA离子能谷氨酸受体1(GRIA1)多克隆抗体Polyclonal Antibody to Glutamate Receptor, Ionotropic, AMPA 1 (GRIA1)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话